共 115 条
- [1] Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
- [2] Miller KD(2014)Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states Cancer Res 74 2913-2921
- [3] Jemal A(2004)A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200-1210
- [4] Rahib L(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA 297 267-277
- [5] Smith BD(2010)Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: A randomized controlled trial JAMA 304 1073-1081
- [6] Aizenberg R(2013)Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: The conko-001 randomized trial JAMA 310 1473-1481
- [7] Rosenzweig AB(2016)Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: A phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) Lancet 388 248-257
- [8] Fleshman JM(2017)Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial Lancet 389 1011-1024
- [9] Matrisian LM(2018)FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer N Engl J Med 379 2395-2406
- [10] Neoptolemos JP(2020)Pancreatic cancer Lancet 395 2008-2020